Stocks & Investing
Wed, September 25, 2024
[ 12:00 AM ] - WOPRAI
Tue, September 24, 2024
[ 12:00 AM ] - WOPRAI
Tue, September 17, 2024
[ 12:00 AM ] - WOPRAI
Tue, August 6, 2024
[ 12:00 AM ] - WOPRAI
Thu, July 11, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, June 20, 2024
[ 12:00 AM ] - WOPRAI
Mon, May 6, 2024
[ 12:00 AM ] - WOPRAI
Wed, April 3, 2024
[ 12:00 AM ] - WOPRAI
Tue, March 19, 2024
[ 12:00 AM ] - WOPRAI
Thu, December 14, 2023
[ 12:00 AM ] - WOPRAI
Mon, December 11, 2023
[ 12:00 AM ] - WOPRAI
Mon, November 13, 2023
Thu, September 28, 2023
[ 12:00 AM ] - WOPRAI
Tue, September 5, 2023
[ 12:00 AM ] - WOPRAI
Mon, August 7, 2023
[ 12:00 AM ] - WOPRAI
Fri, June 16, 2023
[ 12:00 AM ] - WOPRAI
Wed, May 3, 2023
[ 12:00 AM ] - WOPRAI
Fri, March 31, 2023
[ 12:00 AM ] - WOPRAI
Fri, March 17, 2023
[ 12:00 AM ] - WOPRAI
Fri, March 10, 2023
[ 12:00 AM ] - WOPRAI
Thu, March 9, 2023
[ 12:00 AM ] - WOPRAI
Mon, December 19, 2022
Wed, November 16, 2022
[ 12:00 AM ] - WOPRAI
Tue, August 23, 2022
[ 12:00 AM ] - WOPRAI
Wed, August 17, 2022
Tue, July 26, 2022
Wed, June 1, 2022 Jason McCarthy Maintained (CAPR) at Strong Buy with Increased Target to $25 on, Sep 25th, 2024
Jason McCarthy of Maxim Group, Maintained "Capricor Therapeutics, Inc." (CAPR) at Strong Buy with Increased Target from $12 to $25 on, Sep 25th, 2024.
Jason has made no other calls on CAPR in the last 4 months.
There are 2 other peers that have a rating on CAPR. Out of the 2 peers that are also analyzing CAPR, 0 agree with Jason's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Jason
- Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $40 on, Tuesday, September 24th, 2024
- Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $8 on, Friday, September 20th, 2024
